Literature DB >> 27126617

Randomised controlled trial to evaluate a physiotherapy-led functional exercise programme after total hip replacement.

B Monaghan1, P Cunningham2, P Harrington3, W Hing4, C Blake5, D O' Dohertya6, T Cusack5.   

Abstract

BACKGROUND: At present, there is an insufficient evidence base to evaluate the effectiveness of physiotherapy following total hip replacement (THR). This study evaluated the effectiveness of a physiotherapy-supervised functional exercise programme between 12 and 18 weeks following THR. These time-points coincide with increased functional demand in patients.
DESIGN: Adequately powered assessor-blinded randomised controlled trial.
SETTING: Patients were recruited at a pre-operative assessment clinic and randomised following surgery. PARTICIPANTS: Sixty-three subjects were randomised to either the usual care group (control, n=31) or the functional exercise+usual care group (n=32).
INTERVENTIONS: Patients in the functional exercise group attended a physiotherapy-supervised functional exercise class twice weekly from 12 to 18 weeks following THR. Patients in the control group followed the usual care protocol with no exercise intervention. MAIN OUTCOME MEASUREMENT: The main outcome measurement tool was the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) questionnaire, and the secondary outcomes included walking speed, hip abduction dynamometry, Short Form 12 physical and mental health scores, and visual analogue pain scale score.
RESULTS: At 18 weeks post surgery, WOMAC function and walking speed improved significantly more in the functional exercise group [mean difference -4.0, 95% confidence interval (CI) -7.0 to 1.0 (P<0.01); mean difference 21.9m, 95% CI 0.60 to 43.3 (P<0.04)] than the control group, but there was no significant difference in hip abductor strength.
CONCLUSION: This study demonstrated that patients who undertake a physiotherapy-led functional exercise programme between 12 and 18 weeks after THR may gain significant functional improvement compared with patients receiving usual care. Clinical trial registration number NCT01683201.
Copyright © 2016 Chartered Society of Physiotherapy. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Late-stage functional exercise; Physiotherapy; Postoperative rehabilitation; Total hip replacement

Mesh:

Year:  2016        PMID: 27126617     DOI: 10.1016/j.physio.2016.01.003

Source DB:  PubMed          Journal:  Physiotherapy        ISSN: 0031-9406            Impact factor:   3.358


  5 in total

1.  Clinical and cost-effectiveness of physiotherapy interventions following total hip replacement: a systematic review and meta-analysis.

Authors:  Francis Fatoye; J M Wright; G Yeowell; T Gebrye
Journal:  Rheumatol Int       Date:  2020-05-25       Impact factor: 2.631

2.  Evaluation of Exercise Interventions and Outcomes After Hip Arthroplasty: A Systematic Review and Meta-analysis.

Authors:  Tobias Saueressig; Patrick J Owen; Jochen Zebisch; Maximilian Herbst; Daniel L Belavy
Journal:  JAMA Netw Open       Date:  2021-02-01

Review 3.  Unsupervised Home Exercises Versus Formal Physical Therapy After Primary Total Hip Arthroplasty: A Systematic Review.

Authors:  Yash P Chaudhry; Hunter Hayes; Zachary Wells; Efstratios Papadelis; Alfonso Arevalo; Timothy Horan; Harpal S Khanuja; Carl Deirmengian
Journal:  Cureus       Date:  2022-09-19

4.  Mobile Robot-Based Gait Training after Total Hip Arthroplasty (THA) Improves Walking in Biomechanical Gait Analysis.

Authors:  Eric Röhner; Anke Mayfarth; Christian Sternitzke; Frank Layher; Andrea Scheidig; Horst-Michael Groß; Georg Matziolis; Sabrina Böhle; Klaus Sander
Journal:  J Clin Med       Date:  2021-05-29       Impact factor: 4.241

Review 5.  The therapeutic validity and effectiveness of physiotherapeutic exercise following total hip arthroplasty for osteoarthritis: A systematic review.

Authors:  Annet Wijnen; Sjoukje E Bouma; Gesine H Seeber; Lucas H V van der Woude; Sjoerd K Bulstra; Djordje Lazovic; Martin Stevens; Inge van den Akker-Scheek
Journal:  PLoS One       Date:  2018-03-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.